New breathing strategy could save lives in ARDS

NCT ID NCT07309783

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a personalized ventilation strategy guided by electrical impedance tomography (EIT) can improve survival in adults with acute respiratory distress syndrome (ARDS). About 574 participants will be randomly assigned to receive either EIT-guided ventilation (including tailored prone positioning and PEEP settings) or standard protective ventilation. The main goal is to see if the EIT-guided approach lowers 28-day mortality.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Electrical impedance tomography (EIT)-guided ventilation strategy (including prone positioning and PEEP titration)

What this could lead to

If successful, this could provide a more effective way to ventilate ARDS patients, potentially reducing deaths and time on breathing machines.

What could go wrong

This is an early-stage trial (not yet recruiting) with 574 participants. The EIT-guided approach may not improve outcomes over standard care, and results may not apply to all ARDS patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lung injury acute respiratory distress syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, 100730, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••